Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells

Immunity

Volumn 8, Issue 4, 1998, Pages 461-471

  Hitoshi, Yasumichi ^a,b   Lorens, James ^a,c   Kitada, Shin Ichi ^d   Fisher, Joan ^a   LaBarge, Mark ^a   Ring, Huijun Z ^a   Francke, Uta ^a   Reed, John C ^d   Kinoshita, Shigemi ^a   Nolan, Garry P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c RIGEL PHARMACEUTICALS INC   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; FAS ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0032055478     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80551-8     Document Type: Article

References (51)

1. Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, D.J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
2. Arase, H., Arase, N., and Saito, T. (1995). Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235-1238.
3. Berke, G. (1995). The CTL's kiss of death. Cell 81, 9-12.
4. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
5. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85, 803-815.
6. Bray-Ward, P., Menninger, J., Lieman, J., Desai, T., Mokady, N., Banks, A., and Ward, D.C. (1996). Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. Genomics 32, 1-14.
7. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
8. Cifone, M.G., De Maria, R., Roncaioli, P., Rippo, M.R., Azuma, M., Lanier, L.L., Santoni, A., and Testi, R. (1994). Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180, 1547-1552.
9. Clot, J., Massip, H., and Mathieu, O. (1975). In vitro studies on human B and T cell purified polulations. Immunology 29, 445-453.
10. Cox, D.R., Burmeister, M., Price, E.R., Kim, S., and Myers, R.M. (1990). Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science 250, 245-250.
11. Fernandes-Alnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M., Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Litwack, G., et al. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
12. Francke, L.J., Yang-Feng, T.L., Brissenden, J.E., and Ullrich, A. (1986). Chromosomal mapping of genes involved in growth control. Cold Spring Harb. Symp. Quant. Biol. 2, 855-866.
13. Friesen, C., Herr, I., Krammer, P.H., Debatin, K.M. (1996). Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2, 574-577.
14. Gamen, S., Marzo, I., Anel, A., Pineiro, A., and Naval, J. (1996). CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett. 390, 232-237.
15. Geley, S., Hartmann, B.L., and Kofler, R. (1997). Ceramides induce a form of apoptosis in human acute lymphoblastic. FEBS Lett. 400, 15-18.
16. Ghose, T., Lee, C.L., Fernandez, L.A., Lee, S.H., Raman, R., and Colp, P. (1990). Role of 1q trisomy in tumorigenicity, growth, and metastasis of human leukemic B-cell clones in nude mice. Cancer Res. 50, 3737-3742.
17. Goltsev, Y.V., Kovalenko, A.V., Arnold, E., Varfolomeev, E.E., Brodianskii, V.M., and Wallach, D. (1997). CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272, 19641-19644.
18. Hofmann, K., and Stoffel, W. (1992). PROFILEGRAPH: an interactive graphical tool for protein sequence analysis. Comput. Appl. Biosci. 8, 331-337.
19. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
20. Hu, S., Vincenz, C., Ni, J., Gentz, R., and Dixit, V.M. (1997). I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J. Biol. Chem. 272, 17255-17257.
21. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
22. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
23. Itoh, N., and Nagata, S. (1993). A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937.
24. Jacobsen, M.D., Weil, M., and Raff, M.C. (1996). Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell. Biol. 133, 1041-1051.
25. Jinnai, I., Kusumoto, S., Shiomi, Z., Bessho, M., Saitoh, M., Hirashima, K., Minamihisamatsu, M., Kamiyama, T., and Takase, K. (1990). Transformation of bilineal hybrid acute leukemia to acute lymphoid leukemia: a case report with serial analyses of cytogenetics and gene rearrangement. Am. J. Hematol. 35, 118-124.
26. Kinoshita, S., Su, L., Amano, M., Timmerman, L.A., Kaneshima, H., and Nolan, G.P. (1997). The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6, 235-244.
27. Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., and Nolan, G.P. (1995). Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. USA 92, 9146-9150.
28. Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
29. MacGahon, A.J., Martin, S.J., Bissonnette, R.P., Mahboubi, A., Shi, Y., Mogil, R.J., Nishioka, W.K., and Green, D.R. (1995). The end of the (cell) line: methods for the study of apoptosis in vitro. In Methods in Cell Biology, L.M. Schwartz and B.A. Osborne, eds. (San Diego, CA: Academic Press), pp. 172-173.
30. Mertens, F., Johansson, B., Hoglund, M., and Mitelman, F. (1997). Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasm. Cancer Res. 57, 2765-2780.
31. Mitelman, F., Mertens, F., and Johansson, B. (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet. 15, 417-474.
32. Montel, A.H., Bochan, M.R., Hobbs, J.A., Lynch, D.H., and Brahmi, Z. (1995). Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 166, 236-246.
33. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1)death - inducing signaling complex. Cell 85, 817-827.
34. Owen-Schaub, L.B., Yonehara, S., Crump, W.L.d., and Grimm, E.A. (1992). DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140, 197-205.
35. Oyaizu, N., Than., S., McCloskey, T.W., and Pahwa, S. (1995). Requirement of p56lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem. Biophys. Res. Commun. 213, 994-1001.
36. Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y., and Jacobson, M.D. (1993). Programmed cell death and the control of cell survival: lessons from nervous system. Science 262, 695-700.
37. Richardson, B.C., Lalwani, N.D., Johnson, K.J., and Marks, R.M. (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24, 2640-2645.
38. Schmid, E., and Kohler, J. (1984). Involvement of chromosomes #1 and #11 in three cases with myeloproliferative disease. Cancer Genet. Cytogenet. 11, 121-123.
39. Shah, N.K., Wagner, J., Santos, G., and Griffin, C.A. (1992). Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Cancer Genet. Cytogenet. 61, 183-192.
40. Shu, H.B., Halpin, D.R., and Goeddel, D.V. (1997). Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 6, 751-763.
41. Srinivasula, S.M., Ahmad, M., Ottilie, S., Bullrich, F., Banks, S., Wang, Y., Fernandes-Alnemri, T., Croce, C.M., Litwack, G., Tomaselli, K.J., et al. (1997) FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545.
42. Susin, S.A., Zamzami, N., Castedo, M., Daugas, E., Wang, H.G., Geley, S., Fassy, F., Reed, J.C., and Kroemer, G. (1997). The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 186, 25-37.
43. Tagawa, M., Nakauchi, H., Herzenberg, L.A., and Nolan, G.P. (1986). Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc. Natl. Acad. Sci. USA 83, 3422-3426.
44. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A., and Reed, J.C. (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80, 279-284.
45. Tewari, M., and Dixit, V.M. (1995). Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
46. Waghray, M., Rowley, J.D., Reddy, P.P., and Reddy, S.V. (1986). A cytogenetic study of children in India with acute lymphocytic leukemia: correlation with clinical data. Cancer Genet. Cytogenet. 23, 225-237.
47. Walter, M.A., Spillett, D.J., Thomas, P., Weissenbach, J., and Goodfellow, P.M. (1994). A method for constructing radiation hybrid maps of whole genomes. Nat. Genet. 7, 22-28.
48. Williams, A.F., and Barclay, A.N. (1988). The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 6, 381-405
49. Yip, M.Y., Sharma, P., and White, L. (1991). Acute myelomonocytic leukemia with bone marrow eosinophilia and inv(16)(p13q22), t(1;16)(q32;q22). Cancer Genet. Cytogenet. 51, 235-238.
50. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
51. Zhang, J., Alter, N., Reed, J.C., Borner, C., Obeid, L.M., and Hannun, Y.A. (1996). Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA 93, 5325-5328.